LINC00184 promotes esophageal squamous cell carcinoma progression via DNMT1‑mediated methylation of the NDRG2 promoter and PI3K/AKT pathway activation
Oncology Letters · 28.04.2026 · 32 (1) · 1-13
DOI: 10.3892/ol.2026.15628 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 28.04.2026. Verfasst von Junjun Guo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Shaanxi Provincial Tumor Hospital, Xi'an, Shaanxi 710061, P.R. China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Shaanxi Provincial Tumor Hospital, Xi'an, Shaanxi 710061, P.R. China.
- Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
- Department of Radiation Oncology, Shaanxi Provincial Tumor Hospital, Xi'an, Shaanxi 710061, P.R. China.
- Department of Thoracic Surgery, Shaanxi Provincial Tumor Hospital, Xi'an, Shaanxi 710061, P.R. China.
- Department of Internal Medicine, Shaanxi Provincial Tumor Hospital, Xi'an, Shaanxi 710061, P.R. China.
Zitieren
APA
Guo, J., Fu, S., Liu, J., Li, L., Zhao, J., Wang, F., Wu, W., Chen, X., & Li, E. (2026). LINC00184 promotes esophageal squamous cell carcinoma progression via DNMT1‑mediated methylation of the NDRG2 promoter and PI3K/AKT pathway activation. Oncology Letters, 32(1), 1-13. https://doi.org/10.3892/ol.2026.15628
Vancouver
Guo J, Fu S, Liu J, Li L, Zhao J, Wang F, et al. LINC00184 promotes esophageal squamous cell carcinoma progression via DNMT1‑mediated methylation of the NDRG2 promoter and PI3K/AKT pathway activation. Oncology Letters. 2026;32(1):1-13. doi:10.3892/ol.2026.15628
BibTeX
@article{Guo2026,
author = {Guo, Junjun and Fu, Shenbo and Liu, Jia and Li, Lina and Zhao, Jin and Wang, Fenggang and Wu, Wenan and Chen, Xu and Li, Enxiao},
title = {LINC00184 promotes esophageal squamous cell carcinoma progression via DNMT1‑mediated methylation of the NDRG2 promoter and PI3K/AKT pathway activation},
journal = {Oncology Letters},
year = {2026},
volume = {32},
number = {1},
pages = {1--13},
doi = {10.3892/ol.2026.15628}
}
EUVIMED